Search results for: “Biotalys”

Summary: Biotalys (Euronext: BTLS) has announced a strategic refocus to prioritize its most advanced protein-based biocontrol programs, including EVOCA NG and BioFun-6. The initiative is designed to reduce total cash burn by €20 million through 2028, streamlining operations and right-sizing the organization to accelerate the path toward commercializing its precision biocontrol pipeline. Biotalys Announces Strategic…

Summary: Biotalys has announced a strategic refocus to concentrate resources on its most advanced protein-based biocontrol programs, including EVOCA NG and BioFun-6. This restructuring aims to reduce total cash burn by €20 million through 2028, streamlining operations and right-sizing the organization to accelerate the path to commercialization and long-term value creation. Biotalys Proceeds with Strategic…

Summary: Biotalys has announced a strategic refocus to prioritize its most advanced protein-based biofungicide programs, including EVOCA NG and BioFun-6. To streamline operations and extend its financial runway, the company is suspending early-stage activities and reducing its workforce by 30 employees. This restructuring is expected to reduce total cash burn by €20 million through the…

Biotalys has achieved a historic milestone with the announcement that it has received regulatory approval from the U.S. EPA for EVOCA™. This marks the first protein-based biofungicide of its kind to secure such approval, validating the company’s AGROBODY™ technology and paving the way for sustainable protection of high-value fruits and vegetables. Biotalys Receives Regulatory Approval…

Biotalys (Euronext: BTLS) is excited to announce it has received regulatory approval from the U.S. Environmental Protection Agency (EPA) for its first biofungicide, EVOCA™*. This product was developed using Biotalys’ AGROBODY™ technology platform and is the first protein-based biofungicide of its kind to be approved by the EPA. EVOCA is a precision biocontrol solution with…

Biotalys has achieved a monumental regulatory milestone with the U.S. EPA approval of EVOCA™, the first protein-based biofungicide of its kind. This approval validates the company’s proprietary AGROBODY™ technology platform and paves the way for a new generation of sustainable crop protection tools that offer a novel mode of action against resistance-prone fungal diseases. Biotalys…

Biotalys Advances Toward Regulatory Milestones for EVOCA™ in the United States and Europe Biotalys, a next-generation Agricultural Technology (AgTech) company based in Belgium, has announced key progress in the regulatory approval process for its groundbreaking protein-based biocontrol product, EVOCA™. This marks a major step forward in the company’s mission to revolutionize crop protection through sustainable,…

Biotalys Reports Strong Field Trial Results for BioFun-6 Biotalys (Euronext Brussels: BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for sustainable crop protection, today announced strong performance from initial field trials with one of its lead candidates for BioFun-6, the company’s second biocontrol program against Botrytis and powdery mildew in fruits and vegetables.…

Biotalys (Euronext Brussels: BTLS), an innovative AgTech company specializing in protein-based biocontrol solutions for sustainable crop protection, has announced the appointment of Kamal El Mernissi as Chief Business Development Officer (CBDO). With over 15 years of leadership experience across agriculture, sales, and marketing, Mr. El Mernissi will spearhead Biotalys’ efforts to establish strategic partnerships and…